GLP-2 Analogs Market Size, Share & Industry Analysis, By Drug (Teduglutide and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies and Online & Retail Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI113558

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Short Bowel Syndrome, By Key Countries, 2025
2. Pipeline Analysis, By Key Players
3. New Product Launches, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
5. Regolatory and Reimbursement Scenario, By Key Countries/Region
Global GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Nestlé
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Takeda Pharmaceutical Company Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. OxThera
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Zealand Pharma
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Ironwood
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Hanmi Pharm Co., Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Jaguar Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Merck KGaA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. EnteraBio Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Short Bowel Syndrome, By Key Countries, 2025
2. Pipeline Analysis, By Key Players
3. New Product Launches, By Key Players
4. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
5. Regolatory and Reimbursement Scenario, By Key Countries/Region
Global GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa GLP-2 Analogs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Drug
  1. Teduglutide
  2. Others
2. Market Analysis, Insights and Forecast – By Route of Administration
  1. Oral
  2. Parenteral
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Online & Retail Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2025)
2. Company Profiles
  1. Nestlé
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Takeda Pharmaceutical Company Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. OxThera
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Zealand Pharma
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Ironwood
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Hanmi Pharm Co., Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Jaguar Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Merck KGaA
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. EnteraBio Ltd.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global GLP-2 Analogs Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global GLP-2 Analogs Market Value Share (%), by Drug, 2025 & 2034

Figure 3: Global GLP-2 Analogs Market Value Share (%), by Route of Administration, 2025 & 2034

Figure 4: Global GLP-2 Analogs Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 5: Global GLP-2 Analogs Market Value Share (%), by Region, 2025 & 2034

Figure 6: North America GLP-2 Analogs Market Value (USD billion), by Drug, 2025 & 2034

Figure 7: North America GLP-2 Analogs Market Value Share (%), by Drug, 2025

Figure 8: North America GLP-2 Analogs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 9: North America GLP-2 Analogs Market Value Share (%), by Route of Administration, 2025

Figure 10: North America GLP-2 Analogs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 11: North America GLP-2 Analogs Market Value Share (%), by Distribution Channel, 2025

Figure 12: North America GLP-2 Analogs Market Value (USD billion), By Country, 2025 & 2034

Figure 13: North America GLP-2 Analogs Market Value Share (%), By Country, 2025

Figure 14: Europe GLP-2 Analogs Market Value (USD billion), by Drug, 2025 & 2034

Figure 15: Europe GLP-2 Analogs Market Value Share (%), by Drug, 2025

Figure 16: Europe GLP-2 Analogs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 17: Europe GLP-2 Analogs Market Value Share (%), by Route of Administration, 2025

Figure 18: Europe GLP-2 Analogs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 19: Europe GLP-2 Analogs Market Value Share (%), by Distribution Channel, 2025

Figure 20: Europe GLP-2 Analogs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 21: Europe GLP-2 Analogs Market Value Share (%), By Country/ Sub-region, 2025

Figure 22: Asia Pacific GLP-2 Analogs Market Value (USD billion), by Drug, 2025 & 2034

Figure 23: Asia Pacific GLP-2 Analogs Market Value Share (%), by Drug, 2025

Figure 24: Asia Pacific GLP-2 Analogs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 25: Asia Pacific GLP-2 Analogs Market Value Share (%), by Route of Administration, 2025

Figure 26: Asia Pacific GLP-2 Analogs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 27: Asia Pacific GLP-2 Analogs Market Value Share (%), by Distribution Channel, 2025

Figure 28: Asia Pacific GLP-2 Analogs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 29: Asia Pacific GLP-2 Analogs Market Value Share (%), By Country/ Sub-region, 2025

Figure 30: Latin America GLP-2 Analogs Market Value (USD billion), by Drug, 2025 & 2034

Figure 31: Latin America GLP-2 Analogs Market Value Share (%), by Drug, 2025

Figure 32: Latin America GLP-2 Analogs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 33: Latin America GLP-2 Analogs Market Value Share (%), by Route of Administration, 2025

Figure 34: Latin America GLP-2 Analogs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 35: Latin America GLP-2 Analogs Market Value Share (%), by Distribution Channel, 2025

Figure 36: Latin America GLP-2 Analogs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 37: Latin America GLP-2 Analogs Market Value Share (%), By Country/ Sub-region, 2025

Figure 38: Middle East & Africa GLP-2 Analogs Market Value (USD billion), by Drug, 2025 & 2034

Figure 39: Middle East & Africa GLP-2 Analogs Market Value Share (%), by Drug, 2025

Figure 40: Middle East & Africa GLP-2 Analogs Market Value (USD billion), by Route of Administration, 2025 & 2034

Figure 41: Middle East & Africa GLP-2 Analogs Market Value Share (%), by Route of Administration, 2025

Figure 42: Middle East & Africa GLP-2 Analogs Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 43: Middle East & Africa GLP-2 Analogs Market Value Share (%), by Distribution Channel, 2025

Figure 44: Middle East & Africa GLP-2 Analogs Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 45: Middle East & Africa GLP-2 Analogs Market Value Share (%), By Country/ Sub-region, 2025

Figure 46: Global GLP-2 Analogs Market Share (%), By Company, 2025

List of Tables

Table 1: Global GLP-2 Analogs Market Revenue (USD billion) Forecast, by Drug, 2021–2034

Table 2: Global GLP-2 Analogs Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 3: Global GLP-2 Analogs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 4: Global GLP-2 Analogs Market Revenue (USD billion) Forecast, by Region, 2021-2034

Table 5: North America GLP-2 Analogs Market Revenue (USD billion) Forecast, by Drug, 2021–2034

Table 6: North America GLP-2 Analogs Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 7: North America GLP-2 Analogs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 8: North America GLP-2 Analogs Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 9: Europe GLP-2 Analogs Market Revenue (USD billion) Forecast, by Drug, 2021–2034

Table 10: Europe GLP-2 Analogs Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 11: Europe GLP-2 Analogs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 12: Europe GLP-2 Analogs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 13: Asia Pacific GLP-2 Analogs Market Revenue (USD billion) Forecast, by Drug, 2021–2034

Table 14: Asia Pacific GLP-2 Analogs Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 15: Asia Pacific GLP-2 Analogs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 16: Asia Pacific GLP-2 Analogs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 17: Latin America GLP-2 Analogs Market Revenue (USD billion) Forecast, by Drug, 2021–2034

Table 18: Latin America GLP-2 Analogs Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 19: Latin America GLP-2 Analogs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 20: Latin America GLP-2 Analogs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

Table 21: Middle East & Africa GLP-2 Analogs Market Revenue (USD billion) Forecast, by Drug, 2021–2034

Table 22: Middle East & Africa GLP-2 Analogs Market Revenue (USD billion) Forecast, by Route of Administration, 2021–2034

Table 23: Middle East & Africa GLP-2 Analogs Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 24: Middle East & Africa GLP-2 Analogs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 150

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com